Literature DB >> 10790787

Testing different formats for communicating colorectal cancer risk.

I M Lipkus1, Y Crawford, K Fenn, M Biradavolu, R A Binder, A Marcus, M Mason.   

Abstract

This study assessed the extent to which different formats of informing men and women age 50 and over of the risks of colorectal cancer (CRC) affected their perceptions of their absolute and comparative (self versus other) 10-year and lifetime risks; emotional reactions about getting CRC; and screening intentions. Forty-four men and 78 women received information about the absolute lifetime risk of getting CRC. In addition, participants either did or did not receive information about (1) lifetime risk of getting CRC compared with other cancers, and (2) risk factors for CRC (age and polyps). Participants who received risk factors information were more likely to increase their perceived absolute 10-year and lifetime risks of getting CRC compared with participants who did not receive risk factors information. In addition, participants who received risk factors information were more likely to believe age was related to getting CRC and felt at greater risk for having polyps compared with participants who did not receive this information. None of the experimental conditions affected how worried, anxious, and fearful participants felt about getting CRC, nor did they affect screening intentions. Independent of experimental condition, participants tended to increase their intentions to get screened for CRC in the next year or two. Intention to be screened was more pronounced among participants who had been screened via a fecal occult blood test (FOBT) or sigmoidoscopy (SIG). Implications for the design of interventions involving the communication of CRC risks are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10790787     DOI: 10.1080/108107399126841

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  7 in total

1.  Impact of delivery models on understanding genomic risk for type 2 diabetes.

Authors:  S B Haga; W T Barry; R Mills; L Svetkey; S Suchindran; H F Willard; G S Ginsburg
Journal:  Public Health Genomics       Date:  2014-02-27       Impact factor: 2.000

2.  The potential of a placebo/nocebo effect in pharmacogenetics.

Authors:  S B Haga; L R Warner; J O'Daniel
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

3.  Testing Map Features Designed to Convey the Uncertainty of Cancer Risk: Insights Gained From Assessing Judgments of Information Adequacy and Communication Goals.

Authors:  Dolores J Severtson
Journal:  Sci Commun       Date:  2015-02

4.  "I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.

Authors:  Erin Linnenbringer; J Scott Roberts; Susan Hiraki; L Adrienne Cupples; Robert C Green
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

5.  Making decisions in a complex information environment: evidential preference and information we trust.

Authors:  Vetta L Sanders Thompson
Journal:  BMC Med Inform Decis Mak       Date:  2013-12-06       Impact factor: 2.796

6.  Understanding test accuracy research: a test consequence graphic.

Authors:  Penny Whiting; Clare Davenport
Journal:  Diagn Progn Res       Date:  2018-02-01

7.  How should risk be communicated to children: a cross-sectional study comparing different formats of probability information.

Authors:  Fiona Ulph; Ellen Townsend; Cris Glazebrook
Journal:  BMC Med Inform Decis Mak       Date:  2009-06-05       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.